HiRO and CluePoints Partnership Offers RBQM Opportunities in China


Harvest Integrated Research Organization (HiRO), a Shanghai-based Clinical Research Organization, has collaborated with CluePoints, to provide Risk-Based Quality Management (RBQM) expertise and technology in the Chinese region. This partnership will increase clinical trial efficiency and reduce deviation and bias to obtain accurate patient outcomes.

CluePoints' cloud-based products are deployed to support traditional on-site monitoring, medical review, and quality to drive an RBQM approach to study execution and ultimately achieve ICH E6 (R2) compliance.

The US Food and Drug Administration is also currently working with CluePoints as part of a cooperative research and development agreement (CRADA) to utilize CSM technology to inform the site inspection process and develop advanced statistical tests to identify moderators of treatment effect and analyze real-world evidence.

HiRO and CluePoints Partnership Offers RBQM Opportunities in China

Related Videos
Greg Ball, Founder, ASAP Process Consulting image credit screen shot from video
Janice Chang, CEO, TransCelerate BioPharma @ video screenshot.
Applied Clinical Trials and LabConnect
Cat Hall endpoint Clinical
OM1 Sonja Wustrack
Related Content
© 2023 MJH Life Sciences

All rights reserved.